Seville study of people with HIV at risk for anal cancer
Part of Cancer, Digestive system, Immune system & allergy, Infections clinical trials.
This study follows people living with HIV who may be at higher risk for anal cancer. It aims to better understand risk and outcomes, which could help guide future screening or prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed HIV infection
- Your HIV diagnosis must be documented by blood test results (ELISA and western blot)
- You can understand the study and choose to participate (informed consent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at better ways to screen for anal cancer and its early warning signs in women living with HIV. Early detection could help prevent cancer from developing, so joining may help you get closer check-ups.
This study looks at using a simple swab to screen for HPV (the virus that can cause anal cancer) in people living with HIV. By collecting a sample from the anal area, the study aims to find a less invasive way to check for risk, helping you avoid more uncomfortable procedures unless needed.
This trial tests a prevention program for anal cancer in men who have sex with men who are at higher risk, such as those with HIV or taking PrEP. It aims to find and treat early signs of anal cancer to stop it from developing.
This study is screening gay and bisexual men for anal cancer by taking a swab sample. It aims to find early signs of cancer so it can be treated early.
This study is looking at ways to screen for anal cancer in people who are at higher risk, such as those with weakened immune systems or a history of abnormal cells in the lower genital tract. It aims to find better methods for early detection.
This study tests if a probiotic called EXE-346 can help clear anal high-grade squamous intraepithelial lesions (HSIL), a precancerous condition, in people with HIV who are on effective antiretroviral therapy. If you have anal HSIL that wasn't fully removed by biopsy, you may be able to join.
Hear when a new Anal Squamous Intraepithelial Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.